🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
32.95
-1.74 (-5.02%)
Nov 20, 2026, 3:04 PM CST

SHE:300573 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
537.82393.71370.12480.42515.45686.36
Cash & Short-Term Investments
537.82393.71370.12480.42515.45686.36
Cash Growth
41.71%6.37%-22.96%-6.80%-24.90%1744.12%
Accounts Receivable
378.3325.92277.93252.1194.96170.62
Other Receivables
3.612.093.373.934.625.84
Receivables
381.91328.02281.3256.03199.58176.46
Inventory
201.02189.23153.6136.03122.2792.33
Other Current Assets
20.0119.7824.932.7127.8729.27
Total Current Assets
1,141930.73829.92905.19865.17984.42
Property, Plant & Equipment
1,5691,301992.22837.35695.92548.6
Long-Term Investments
15.3111.6710---
Other Intangible Assets
208.42222.62134.5778.2927.6622.83
Long-Term Deferred Tax Assets
20.6919.6822.538.5723.7730.45
Long-Term Deferred Charges
1.553.464.44118.76105.0360.77
Other Long-Term Assets
39.6450.017445.6865.3939.78
Total Assets
2,9952,5392,1282,0241,7831,687

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
2735.4917.7317.5719.4613.31
Accrued Expenses
99.11218.16178.33125.36103.97108.91
Short-Term Debt
-70.05200.1770.06-100
Current Portion of Leases
7.277.66.286.877.124.18
Current Income Taxes Payable
111.7356.322.845.74-11.69
Current Unearned Revenue
3.161.883.466.762.016.11
Other Current Liabilities
355.74111.3432.6727.7619.8922.63
Total Current Liabilities
604.01500.83461.48260.12152.45266.83
Long-Term Debt
88-----
Long-Term Leases
10.314.388.862.226.697.1
Long-Term Unearned Revenue
61.1455.7264.1371.5871.568.42
Total Liabilities
763.46560.93534.48333.92230.63342.35

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
354.92246.43175.25124.5988.5688.1
Additional Paid-In Capital
622.71829.93866.51891.01852.36782.68
Retained Earnings
1,252900.27551.4674.32611.4479
Treasury Stock
------5.28
Comprehensive Income & Other
1.421.42----
Total Common Equity
2,2321,9781,5931,6901,5521,344
Shareholders' Equity
2,2321,9781,5931,6901,5521,344
Total Liabilities & Equity
2,9952,5392,1282,0241,7831,687

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
105.5882.03215.3179.1513.81111.28
Net Cash (Debt)
432.24311.69154.81401.27501.64575.08
Net Cash Growth
76.00%101.33%-61.42%-20.01%-12.77%-
Net Cash Per Share
1.210.870.441.141.431.77
Filing Date Shares Outstanding
354.92357.32355.76354.08352.34350.52
Total Common Shares Outstanding
354.92357.32355.76354.08352.34350.52
Working Capital
536.74429.9368.44645.07712.72717.59
Book Value Per Share
6.295.544.484.774.413.84
Tangible Book Value
2,0231,7551,4591,6121,5251,322
Tangible Book Value Per Share
5.704.914.104.554.333.77
Buildings
-528.48517.5476.93470.69350.19
Machinery
-964.78759.99711.75534.35481.36
Construction In Progress
-380.26196.85106.1670.1234.94